In vivo studies of gene expression via transient transgenesis using lipid-DNA delivery

DNA and Cell Biology

Volumn 18, Issue 7, 1999, Pages 533-547

  McClarrinon, Molly ^a   Gilkey, Leslie ^b   Watral, Virginia ^b   Fox, Bryan ^a,e   Bullock, Clayton ^a,d   Fradkin, Lee ^a   Liggitt, Denny ^a,c   Roche, Lisa ^a   Bussey, Lee B ^a   Fox, Ed ^a   Gorman, Cornelia ^a,f  

^a Urigen Pharmaceuticals Inc   (United States)

^b OREGON STATE UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e PURDUE UNIVERSITY   (United States)

^f DNA Bridges Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 (9 OCTADECENOYL)ETHYL] 2 (8 HEPTADECENYL) 3 (HYDROXYETHYL)IMIDAZOLINIUM; CHLORAMPHENICOL ACETYLTRANSFERASE; CHOLESTEROL; DNA; GENE PRODUCT; LIPID; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ENDOTHELIUM CELL; EXPRESSION VECTOR; FEMALE; GENE EXPRESSION; GENE TARGETING; IN VIVO STUDY; INTRON; MOUSE; NONHUMAN; POLYADENYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; TRANSGENE; VASCULAR ENDOTHELIUM;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CHLORAMPHENICOL O-ACETYLTRANSFERASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION; GENE TARGETING; GENES, REPORTER; GENETIC ENGINEERING; GENETIC VECTORS; GRANULOCYTE COLONY-STIMULATING FACTOR; IMIDAZOLES; LIPID METABOLISM; LIPIDS; LUNG; MICE; PANCREAS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN; TIME FACTORS; TRANSFECTION;

ANIMALIA; FELIS CATUS;

EID: 0032771134     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454999315088     Document Type: Article

References (54)

1. BARRETT, N.L., and CARMICHAEL, G.G. (1991). Splice site requirement for the efficient accumulation of polyoma virus late mRNAs. Nucleic Acids Res. 19, 3011-3017.
2. BERGET, S.M. (1995). Exon recognition in vertebrate splicing. J. Biol. Chem. 270, 2411-2414.
3. BOSHART, M., WEBER, F., JAHN, G., DORSCH-HASLER, K., FLECKENSTEIN, B., and SCHAFFNER, W. (1985). A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41, 521-526.
4. CAPLEN, N.J., ALTON, E.W., MIDDLETON, P.G., DORIN, J.R., STEVENSON, B.J., GAO, X., DURHAM, S.R., JEFFERY, P.K., HUDSON, M.E., and COUTELLE, C. (1995). Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nature Med. 1, 39-46.
5. CARSWELL, S., and ALWINE, J.C. (1989). Efficiency of utilization of the simian virus 40 late polyadenylation site: effects of upstream sequences. Mol. Cell. Biol. 9, 4248-4258.
6. CHOI, T., HUANG, M., GORMAN, C., and JAENISCH, R. (1991). A generic intron increases gene expression in transgenic mice. Mol. Cell. Biol. 11, 3070-3074.
7. COLMAN, A. (1998). Production of therapeutic proteins in the milk of transgenic livestock. Biochem. Soc. Symp. 63, 141-147.
8. COLOMA, M.J., HASTINGS, A., WIMS, L.A., and MORRISON, S.L. (1992). Novel vectors for the expression of antibody molecules using variable regions generated by polymerase chain reaction. J. Immunol. Methods 152, 89-104.
9. CULLEN, B.R. (1996). Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism. Cell 46, 973-982.
10. DOERFLER, W., SCHUBBER, R., HELLER, H., KRAMMER, C. HILGER-EVERSHIEM, K., KNOBLAUCH, M., and REMUS, R. (1997). Integration of foreign DNA and its consequences in mammalian systems. Trends Biotechnol. 15, 297-301.
11. EVANS, M.J., and SCARPULLA, R.C. (1989). Introns in the 3′-untranslated region can inhibit chimeric CAT and β-galactosidase gene expression. Gene 84, 135-142.
12. EVANS, M.J., CARLTON, M.B. and RUSS, A.P. (1997). Gene trapping and functional genomics. Trends Genet. 13, 370-374.
13. FELGNER, P.L., GADEK, T.R., HOLM, M., ROMAN, R., CHAN, H.W., WENZ, M., NORTHROP, J.P., RINGOLD, G.M., and DANIELSEN, M. (1987). Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA 84, 7413-7417.
14. FELGNER, J.H., KUMAR, R., SRIDHAR, C.N., WHEELER, C.J., TSAI, Y.J., BORDER, R., RAMSEY, P., MARTIN, M., and FELGNER, P.L. (1994). Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J. Biol. Chem. 269, 2550-2561.
15. FELGNER, P.L., TSAI, Y.J., SUKHU, L., WHEELER, C.J., MANTHORPE, M., MARSHALL, J., and CHENG, S.H. (1995). Improved cationic lipid formulations for in vitro gene therapy. Ann. N.Y. Acad. Sci. 772, 126-139.
16. FU, X.Y., GE, H., and MANLEY, J.L. (1988). The role of the polypyrimidine stretch at the SV40 early pre-mRNA 3′ splice site in alternative splicing. EMBO J. 7, 809-817.
17. GORMAN, C.M., MOFFAT, L.F., and HOWARD, B.H. (1982). Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2, 1044-1051.
18. HARMS, J.S., and SPLITTER, G.A. (1995). Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter. Hum. Gene Ther. 6, 1291-1297.
19. HOFLAND, H.E., SHEPHARD, L., and SULLIVAN, S.M. (1996). Formation of stable cationic lipid/DNA complexes for gene transfer. Proc. Natl. Acad. Sci. USA 93, 7305-7309.
20. HUANG, M.T.F., and GORMAN, C.M. (1990a). Intervening sequences increase the efficiency of RNA 3′ processing and accumulation of cytoplasmic RNA. Nucleic Acids Res. 18, 937-947.
21. HUANG, M.T.F., and GORMAN, C.M. (1990b). The simian virus 40 small t intron, present in many common expression vectors, leads to aberrant splicing. Mol. Cell. Biol. 10, 1805-1810.
22. KEDES, D.H., and STEITZ, J.A. (1988). Correct in vitro splicing of the mouse immunoglobulin kappa light-chain pre-RNA is dependent on 5′ splice-site position even in the absence of transcription. Genes Dev. 2, 1448-1459.
23. LEGENDRE, J.Y., and SZOKA, F.C., JR. (1992). Delivery of plasmid DNA into mammalian cell lines using pH-sensitive liposomes: comparison with cationic liposomes. Pharmacol. Res. 9, 1235-1242.
24. LIU, Y., LIGGITT, D., ZHONG, W., TU, G., GAENSLER, K., and DEBS, R. (1995). Cationic liposome-mediated intravenous gene delivery. I. Biol. Chem. 270, 24864-24870.
25. LIU, Y., MOUNKES, L.C., LIGGITT, H.D., BROWN, C.S., SOLODIN, I., HEATH, T.D., and DEBS, R.J. (1997a). Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Nature Biotechnol. 15, 167-173.
26. LIU, F., QI, H., HUANG, L., and LIU, D. (1997b). Factors controlling the efficiency of cationic lipid-mediated transfection in vitro via intravenous administration. Gene Ther. 4, 517-523.
27. LOSER, P., JENNINGS, G.S., STRAUSS, M., and SANDIG, V. (1998). Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFkappaB. J Virol 72, 180-190.
28. MALESZKA, R., DE COUET, H.G., and MIKLOS, G.L. (1998) Data transferability from model organisms to human beings: insights from the functional genomics of the flightless region of Drosophila. Proc. Natl. Acad. Sci. USA 95, 3731-3736.
29. MALONE, R.W., HICKMAN, M.A., LEHMANN-BRUISMA, K., SIH, T.R., WALZEM, R., CARLSON, D.M., and POWELL, J.S. (1994). Dexamethasone enhancement of gene expression after direct hepatic DNA injection. J. Biol. Chem. 269, 29903-29907.
30. MACGREGOR, G.R., and CASKEY, C.T. (1989). Construction of plasmids that express E. coli β-galactosidase in mammalian cells. Nucleic Acids Res. 17, 2365.
31. MCCLEAN, J.W., FOX, E.A., BALUK, P., BOLTON, P.B., HASKELL, A., PEARLMAN, R., THURSTON, G., UMEMOTO, E.Y., and MCDONALD, D.M. (1997). Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice. Am. J. Physiol. 273, H387-H404.
32. MCDONALD, R.J., LIGGITT, H.D., ROCHE, L., NGUYEN, H.T., PEARLMAN, R., RAABE, O.G., BUSSEY, L.B., and GORMAN, C.M. (1998). Aerosol delivery of lipid:DNA complexes to lungs of rhesus monkeys. Pharmacol. Res. 15, 671-679.
33. MIDDLETON, T., and SUGDEN, B. (1994). Retention of plasmid DNA in mammalian cells is enhanced by binding of the Epstein-Barr virus replication protein EBNA1. J. Virol. 68, 4067-4071.
34. NISBET, L.J., and MOORE, M. (1997). Will natural products remain an important source of drug research for the future? Curr. Opin. Biotechnol. 8, 708-712.
35. PETITCLERC, D., ATTAL, J., THERON, M.C., BEARZOTTI, M., BOLIFRAUD, P., KANN, G., STINNAKRE, M.G., POINTU, H., PUISSANT, C., and HOUDEBINE, L.M. (1995). The effect of various introns and transcription terminators on the efficiency of expression vectors in various cultured cell lines and in the mammary gland of transgenic mice. J. Biotechnol. 40, 169-178.
36. PHILIP, R., LIGGITT, D., PHILIP, M., DAZIN, P., and DEBS, R. (1993). In vitro gene delivery: efficient transfection of T lymphocytes in adult mice. J. Biol. Chem. 268, 16087-16090.
37. RADLER, J.O., KOLTOVER, I., SALDITT, T., and SAFINYA, C.R. (1997). Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes. Science 275, 810-814.
38. RASTAN, S., and BEELEY, L.J. (1997). Functional genomics: going forwards from the databases. Curr. Opin. Genet. Dev. 7, 777-783.
39. SAMBROOK, J., FRITSCH, E.F., and MANIATIS, T. (1989). Molecular Cloning: A Laboratory Manual, ed 2. N. Ford, C. Nolan, and M. Ferguson, eds. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY) 235-240.
40. SEED, B., and SHEEN, J.Y. (1988). A simple phase-extraction assay for chloramphenicol aceyltransferase activity. Gene 67, 271-277.
41. SHANI, M., BARASH, I., NATHAN, M., RICCA, G., SEARFOSS, G.H., DEKEL, I., FAERMAN, A., GIVOL, D., and HURWITZ, D.R. (1992). Expression of human serum albumin in the milk of transgenic mice. Transgen. Res. 1, 195-208.
42. SMITHIES, O. (1993). Animal models of human genetic diseases. Trends Genet. 9, 112-116.
43. SOLODIN, I., BROWN, C.S., BRUNO, M.S., CHOW, C-Y., JANG, E.-H., and DEBS, R.J. (1995). A novel series of amphiphilic imidazolinium compounds for in vitro and in vivo gene delivery. Biochemistry 34, 13537-13544.
44. STINSKI, M., and ROEHER, T.J. (1985). Activation of the major immediate early gene of human cytomegalovirus by cis-acting elements in the promoter-regulatory sequence and by virus-specific trans-acting components. Virology 55, 431-441.
45. SUGDEN, B., MARSH, K., and YATES, J. (1985). A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus. Mol. Cell. Biol. 5, 410-413.
46. TEMPLETON, N.S., LASIC, D.D., FREDERIK, P.M., STREY. H.H., ROBERTS, D.D., and PAVLAKIS, G.N. (1997). Improved DNA: liposome complexes for increased systemic delivery and gene expression. Nature Biotechnol. 15, 647-652.
47. THIERRY, A.R., LUNARDI-ISKANDAR, Y., BRYANT, J.L., RABINOVICH, P., GALLO, R.C., and MAHAN, L.C. (1995). Systemic gene therapy: biodistribution and long-term expression of a transgene in mice. Proc. Natl. Acad. Sci. USA 92, 9742-9746.
48. WAHLE, E., and KUHN, U. (1997). The mechanism of 3′ cleavage and polyadenylation of eukaryotic pre-RNA. Prog. Nucleic Acids Res. Mol. Biol. 57, 41-71.
49. WIERINGA, B., HOFER, E., and WEISSMANN, C. (1984). A minimal intron length but no specific sequence is required for splicing the rabbit β-globin intron. Cell 37, 915-925.
50. WOHLGEMUTH, J.G., KANG, S.H., BULBOACA, G.H., NAWOTKA, K.A., and CALOS, M.P. (1996). Long-term gene expression from autonomously replicating vectors in mammalian cells. Gene Ther. 3, 503-512.
51. WONG, F.M., REIMER, D.L., and BALLY, M.B. (1996). Cationic lipid binding to DNA: characterization of complex formation. Biochemistry 35, 5756-5763.
52. ZHOU, X., and HUANG, L. (1994). DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action. Biochim. Biophys. Acta 1189, 195-203.
53. ZHU, N., LIGGITT, D., LIU, Y., and DEBS, R. (1993). Systemic gene expression after intravenous DNA delivery into adult mice. Science 261, 209-211.
54. ZHUANG, Y., LEUNG, H., and WIENER, A.M. (1987). The natural 5′ splice site of the simian virus 40 large T antigen can be improved by increasing the base complementary to U1 RNA. Mol. Cell. Biol. 7, 3018-3020.